The ongoing war in the Middle East has not yet caused significant disruptions to global pharmaceutical supply chains, according to industry observations. While the conflict continues to escalate, pharmaceutical companies have maintained their production and distribution networks without major interruptions.
The pharmaceutical industry relies on complex global supply chains that span multiple regions for raw materials, manufacturing, and distribution. Middle Eastern conflicts have historically posed risks to these networks due to the region's strategic location and role in global shipping routes.